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SUMMARY
The transition from transcription initiation to elongation at promoters of primary response genes 
(PRGs) in metazoan cells is controlled by inducible transcription factors, which utilize P-TEFb to 
phosphorylate RNA polymerase II (Pol II) in response to stimuli. Prior to stimulation, a fraction of 
P-TEFb is recruited to promoter-proximal regions in a catalytically inactive state bound to the 
7SK small nuclear ribonucleoprotein (snRNP) complex. However, it remains unclear how and 
why the 7SK snRNP is assembled at these sites. Here we report that the transcriptional regulator 
KAP1 continuously tethers the 7SK snRNP to PRG promoters to facilitate P-TEFb recruitment 
and productive elongation in response to stimulation. Remarkably, besides PRGs, genome-wide 
studies revealed that KAP1 and 7SK snRNP co-occupy most promoter-proximal regions 
containing paused Pol II. Collectively, we provide evidence of an unprecedented mechanism 
controlling 7SK snRNP delivery to promoter-proximal regions to facilitate “on-site” P-TEFb 
activation and Pol II elongation.
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INTRODUCTION
Metazoan cells are capable of rapidly activating transcriptional cascades in response to 
intrinsic and extrinsic insults (stimuli). This capacity is mediated by a specialized 
transcriptional program of primary response genes (PRGs) (Fowler et al., 2011; Hargreaves 
et al., 2009; Smale, 2010), which is essential for tissue homeostasis, cell-fate choice, 
establishment of innate immune responses, and avoidance of malignancy. PRGs are rapidly 
induced in the absence of new protein synthesis and without chromatin remodeling and 
encode proteins necessary for the cell to immediately respond to a stimulus, thereby 
facilitating resolution of the insult (Hargreaves et al., 2009; Ramirez-Carrozzi et al., 2009).
Transcriptional regulation involves a network of inducible transcription factors (TFs) and 
cofactors that orchestrate the precise spatiotemporal synthesis of the proper set of genes in 
response to a stimulus. Prior to stimulation, the transcription preinitiation complex (PIC) 
assembles at promoters to recruit RNA polymerase II (Pol II) and initiate transcription at 
most PRGs (Diamant and Dikstein, 2013; Hargreaves et al., 2009; Smale, 2010), but Pol II 
pauses shortly after transcribing ~20–65 nt downstream of the transcription start site (TSS) 
by the action of negative elongation factors (Adelman and Lis, 2012; Peterlin and Price, 
2006; Yamaguchi et al., 1999). In response to stimuli such as proinflammatory cytokines 
(tumor necrosis factor alpha, henceforth referred to as TNF) and environmental stresses, 
PRGs are rapidly activated by inducible TFs that mediate recruitment of coactivators such as 
positive elongation factors to help relieve Pol II pausing (Barboric et al., 2001; Rahl et al., 
2010). One such elongation factor that has received considerable attention in the last two 
decades is the P-TEFb kinase, a heterodimer of Cyclin T1 or T2 (CycT1/2) and Cyclin-
dependent kinase 9 (Cdk9). P-TEFb phosphorylates the C-terminal domain of Pol II and 
several negative elongation factors to promote the transcriptional pause release (Mancebo et 
al., 1997; Zhou et al., 2012).
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To properly regulate its activity, the majority of P-TEFb is held in a catalytically inactive 
state reversibly bound to the 7SK small nuclear ribonucleoprotein (snRNP), composed of the 
7SK RNA, the kinase inhibitor Hexim1, the 5′-RNA methyl capping enzyme MePCE, and 
the 3′-RNA stability protein Larp7 (He et al., 2008; Jeronimo et al., 2007; Krueger et al., 
2008; Li et al., 2005; Michels et al., 2004; Nguyen et al., 2001; Yik et al., 2003). Although 
the majority of the 7SK snRNP complex exists in the soluble nucleoplasmic fraction, 
previous studies have shown that it is recruited to HIV and cellular promoter-proximal 
regions (Cherrier et al., 2013; D’Orso and Frankel, 2010; Ji et al., 2013; McNamara et al., 
2013). It remains unclear, however, how and why the cell evolved a mechanism to 
selectively position the 7SK snRNP on promoter-proximal regions. We therefore sought to 
(1) identify factors that mediate 7SK snRNP recruitment to promoters and (2) characterize 
the biological significance of this complex in the activation of inducible transcriptional 
programs.
Here we present the unexpected findings that the Kruppel-associated box (KRAB)-
interacting protein 1 (KAP1), also referred to as tripartite motif containing 28 (TRIM28) and 
transcription intermediary factor 1-beta (TIF1β) (Iyengar and Farnham, 2011), directly 
recruits the 7SK snRNP complex to most genes containing promoter-proximal paused Pol II, 
particularly at inducible genes. Recruitment of the KAP1-7SK snRNP complex to promoter-
proximal regions is tightly correlated with Pol II pausing and transcriptional activity, and its 
recruitment regulates the rapid and robust response to stimulation. Although loss of KAP1 
does not alter the recruitment of inducible TFs (nuclear factor κB; NF-κB) to target gene 
promoters in response to stimulation nor PIC assembly, it strongly antagonizes P-TEFb 
recruitment, slowing down Pol II pause release and largely attenuating gene activation. Our 
findings define a mechanism by which the 7SK snRNP complex is recruited to most 
promoter-proximal regions containing transcriptionally engaged Pol II, and explains the 
importance of this localized placement for rapid gene induction in response to stimulation. 
Moreover, our findings further illustrate that HIV evolved its genome to ensure that the virus 
is readily and robustly activated during infection through the placement of KAP1-7SK 
snRNP close to promoter-proximal paused Pol II.
RESULTS
The 7SK snRNP Complex Interacts with the Transcriptional Regulator KAP1/TRIM28/TIF1β
Previous studies have shown that the inhibitory 7SK snRNP complex is recruited to gene 
promoters (Figure 1A). However, the molecular basis of this recruitment mechanism and its 
precise role in the transcriptional cycle have yet to be understood. To identify factors that 
interact with the 7SK snRNP to potentially recruit it to promoters, we employed an affinity 
purification (AP) and mass spectrometry (MS) approach, which has proven to be an efficient 
unbiased and comprehensive method to discover the nature and composition of protein 
complexes. We generated HEK293 T-REx cell lines inducibly expressing a Strep-tagged 
version of the 7SK snRNP component Larp7 (Larp7:S) and GFP:S (negative control). Strep 
AP of Larp7:S from nuclear fractions revealed several specific interactors not present in the 
control sample (Figure 1B). To identify their identity, we subjected the affinity-purified 
products to liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis. High-
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confidence Larp7 interactors (based on their quantitative enrichment relative to control 
samples) are shown in Tables S1 and S2, along with their corresponding hypothetical bands 
in the silver-stained gel of Figure 1B. In addition to the core 7SK snRNP components 
(CycT1, Cdk9, MePCE, and Hexim1) and reversibly bound heterogeneous nuclear 
ribonucleoprotein (hnRNP) proteins, YBOX1 and DDX21 (Calo et al., 2015; Jeronimo et 
al., 2007; Krueger et al., 2008), we also identified one high-confidence interactor, the KAP1 
protein (also known as TRIM28/TIF1β) (Iyengar and Farnham, 2011) (Figures 1B and 1C). 
In contrast to our AP-MS dataset, KAP1 was not identified in a previous Larp7 proteomics 
study (Krueger et al., 2008), probably attributable to the higher affinity of Strep AP 
(compared with regular antibody-mediated immunoprecipitation; IP), thereby leading to 
more sensitivity.
To validate that KAP1 interacts with Larp7 as part of the 7SK snRNP complex, we 
generated HEK293 T-REx cell lines inducibly expressing FLAG-tagged KAP1 (KAP1:F), 
which expresses at similar levels to endogenous KAP1, and GFP:F (Figure S1A). Indeed, 
using nuclear extracts, we detected the primary components of the 7SK snRNP after FLAG 
IP of KAP1:F but not GFP:F, including 7SK RNA but not U6 (another abundant snRNA) 
(Figure 1D). Because we detected the KAP1-Larp7 protein interaction using epitope-tagged 
components, we next performed an IP of endogenous Larp7 (which is constitutively bound 
to the 7SK snRNP; Krueger et al., 2008) to demonstrate that the association occurs in a more 
biologically relevant system. Consistent with the previous results, we detected KAP1 in the 
IP of endogenous Larp7, as well as core 7SK snRNP components, but not when using a 
normal serum (IgG) (Figure 1E). Based on the material loaded, we estimated that about 
10%–15% of the 7SK snRNP interacts with KAP1 in the conditions tested. Importantly, 
whereas the KAP1-Larp7 interaction was largely insensitive to RNase, as expected for a 
direct protein-protein interaction, the KAP1-Cdk9 interaction was RNA dependent (Figure 
1F), indicating that KAP1 recruits P-TEFb through the Larp7 subunit of the 7SK snRNP 
complex.
To further validate the relevance of these findings, we performed high-resolution confocal 
microscopy of endogenous KAP1 and components of the 7SK snRNP and observed 
statistically significant colocalization indices (p value < 0.01) for all protein pair 
combinations in all cells examined (Figure 1G; Figures S1B–S1D), in contrast to 
noninteracting partners (Figure S1E).
To further test whether KAP1 associates with the 7SK snRNP complex through direct 
interaction with Larp7, we performed an in vitro binding assay using affinity-purified 
proteins from HEK293T cells under high-salt conditions. Using this method, we observed 
that Larp7:S directly bound KAP1:F in vitro, as well as MePCE:F, but not to GFP:F (Figure 
1H). Although in the conditions used the KAP1-Larp7 interaction appears not to be 
stoichiometric, it is possible that Larp7 (in the absence of 7SK RNA) is biochemically 
poorly behaved or that the protein-protein interaction requires posttranslational 
modifications to achieve a higher binding affinity. Nonetheless, we have demonstrated using 
various approaches that KAP1 associates with the 7SK snRNP through the Larp7 subunit.
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Given the relevance of P-TEFb in the transcriptional cycle, below we focus on studying the 
function of KAP1 in recruiting the 7SK snRNP to promoter-proximal regions to control Pol 
II pause release.
KAP1 and the 7SK snRNP Complex Co-occupy the HIV Promoter-Proximal Region
Given that KAP1 physically associates with the 7SK snRNP and that KAP1 is also recruited 
to gene promoters (Bunch et al., 2014; Hu et al., 2009), we asked whether both are 
corecruited to the promoter of HIV integrated into a Jurkat CD4+ T cell line known as clone 
E4 (Pearson et al., 2008). Using chromatin immunoprecipitation (ChIP) assays, we detected 
both KAP1 and the 7SK snRNP (Cdk9, Larp7, and Hexim1) at the HIV promoter-proximal 
region surrounding the TSS (5′ long terminal repeat; LTR) but not inside the genome (at 
least with the amplicons used) (Figure 2A).
The presence of duplicated LTRs makes it difficult to assign ChIP signal to individual 
LTRs. Therefore, to distinguish PCR amplifications of the 5′-LTR from the 3′-LTR, we used 
LTR-specific primer sets (+141 and +4230, respectively) (Jadlowsky et al., 2014). We noted 
that KAP1 displayed a preference for the 5′-LTR, consistent with previous reports of it 
occupying the LTR of endogenous retroelements (Iyengar and Farnham, 2011; Rowe et al., 
2010). A minor fraction of KAP1 was also detected at the 3′-LTR of the integrated provirus. 
However, none of the 7SK snRNP components displayed significant enrichment at the 3′-
LTR, demonstrating that the inhibitory snRNP, and the majority of KAP1, primarily co-
occupy the 5′-LTR of HIV. The peak intensity of the 7SK snRNP and KAP1 closely mirrors 
the occupancy profile of promoter-proximal paused Pol II and the PIC (as revealed by the 
occupancy of basal transcription factors Sp1 and TBP) at the promoter (Figure 2A).
Given that HIV integrates randomly and that integration site placement dictates basal 
transcriptional activity (Jordan et al., 2001), we asked whether the occupancy of KAP1 and 
the 7SK snRNP at the HIV promoter was dependent on the integration site, chromatin 
context, and promoter activity. To evaluate this, we performed ChIP-quantitative (q)PCR 
with the primer pair that specifically amplifies the HIV promoter-proximal region and 
measured transcription initiation levels across several cell-based models containing a single 
HIV integrant. Notably, we observed that KAP1 and the 7SK snRNP are recruited only to 
promoters containing a PIC (Sp1 and TBP) and transcriptionally engaged Pol II such as in 
the E4, 2B2D, 8.4, and 9.2 HIV clones (Figures 2B–2E). Conversely, KAP1 and the 7SK 
snRNP do not appear to occupy the promoter of a provirus integrated in chromatin-dense 
regions without noticeable PIC and paused Pol II (6.3 clone; Figure 2F) or a promoter 
containing a mutation that impairs PIC assembly and Pol II recruitment (2B5 clone; Figure 
2G).
Given the correlation between PIC assembly, Pol II pausing, and the presence of the 
KAP1-7SK snRNP complex at promoter-proximal regions, we asked whether the HIV 
genomes in these cell lines are transcriptionally active. To test this, we performed qRT-PCR 
assays to measure levels of promoter-proximal transcripts (indicative of transcription 
initiation) and observed that higher transcript levels (in the E4, 2B2D, 8.4, and 9.2 clones) 
directly correlated with the presence of a promoter-assembled PIC, transcriptionally engaged 
Pol II, and the KAP1-7SK snRNP complex at promoter-proximal regions (Figure 2H). In 
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contrast, the 6.3 and 2B5 clones showed fewer promoter-proximal transcripts (at least 7- to 
10-fold less compared with active promoters). These results are consistent with previous 
evidence demonstrating that 6.3 exhibits very low transcript levels and 2B5 contains a 
nonfunctional promoter (Jordan et al., 2001; Pearson et al., 2008). Taken together, our 
findings indicate that KAP1-7SK snRNP occupies promoter-proximal regions of proviruses 
that show evidence of transcription initiation.
KAP1 Mediates Recruitment of the 7SK snRNP Complex to the HIV and Cellular Promoter-
Proximal Regions
Given that KAP1 associates with the 7SK snRNP and that both are recruited to chromatin, 
we hypothesized that KAP1 recruits the inhibitory snRNP to promoters to control 
transcription elongation. To test this model, we generated Jurkat HIV E4 cell lines 
expressing nontarget (shNT) or KAP1 (shKAP1) small hairpin (sh) RNAs. Importantly, this 
approach yielded efficient knockdown (KD) of KAP1 without significantly affecting the 
stability of 7SK snRNP components (Figure 3A). Given that fluctuations in their levels, such 
as increased Hexim1, have been previously correlated with the release of P-TEFb from the 
7SK snRNP (Liu et al., 2014), we asked whether 7SK snRNP stability is disrupted when 
KAP1 expression is lost. To test this, we performed IP of endogenous Larp7 in the two cell 
lines and quantified levels of coimmunoprecipitated 7SK snRNP components, and observed 
no clear alterations in the levels of Cdk9 and Hexim1 bound to Larp7 in response to KAP1 
KD (Figure 3B). Although we cannot exclude minor fluctuations in the levels of competent 
7SK snRNP, its stability appears for the most part to be KAP1 independent.
Using these cell lines, we then assessed whether KAP1 plays any role in recruiting the 7SK 
snRNP complex to the HIV and cellular gene promoters by ChIP. Importantly, because loss 
of KAP1 resulted in minimal 7SK snRNP disruption, this strategy allowed us to measure 
direct effects of KAP1 loss on the promoter-bound 7SK snRNP pool. Expectedly, KAP1 and 
7SK snRNP components co-occupy the HIV promoter but not intragenic domains (gene 
body) in the control cell line (shNT). However, the occupancy of KAP1 and the 7SK snRNP 
at the HIV promoter was reduced by a factor of ~3- to 5-fold (depending on the subunit) 
upon KAP1 KD (Figure 3C). Although Pol II occupancy at the HIV promoter increased ~2-
fold in response to KAP1 KD, we did not detect any significant increase in Pol II levels at 
the gene body (Figure 3C), probably indicating reduced pause release in the absence of 
KAP1. Notably, PIC assembly (Sp1 and TBP) at the HIV promoter remained unaffected.
Because different HIV clones (E4 and 2B2D) showed evidence of KAP1-7SK snRNP 
recruitment to the promoter-proximal region (Figure 2), we also tested the effect of KAP1 
KD on 7SK snRNP recruitment in another Jurkat HIV clone (2B2D). Remarkably, we 
observed that the effect of KAP1 KD on 7SK snRNP occupancy at the HIV promoter in the 
2B2D clone matches the effect observed on E4 (Figure S2A), suggesting that the results are 
clone independent.
The findings that KAP1 and the 7SK snRNP have been detected at promoter-proximal 
regions of NF-κB-regulated genes (McNamara et al., 2013) prompted us to test whether 
KAP1 mediates 7SK snRNP recruitment to cellular genes as observed with HIV. We chose 
two inflammatory-responsive PRGs, NF-κB inhibitor alpha (NFKBIA, encoding IκBα) and 
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TNF alpha-induced protein 3 (TNFAIP3, encoding A20), due to the presence of a fully 
assembled PIC at their promoters, P-TEFb dependence, Pol II pausing, and a strong and 
rapid induction in the presence of TNF through NF-κB (RelA family member) (Diamant and 
Dikstein, 2013; Smale, 2010). Notably, both PRGs showed evidence of KAP1 and 7SK 
snRNP recruitment to promoters but not to gene bodies, as well as promoter-proximal 
paused Pol II prior to stimulation (Figures 3D and 3E). Strikingly, KAP1 KD produced a 
sharp reduction (~3- to 10-fold depending on the subunit) in the occupancy of the 7SK 
snRNP at both gene promoters. Similar to the HIV promoter, PIC assembly (Sp1 and TBP) 
at both promoters remains mostly unaffected upon KAP1 KD (Figures 3D and 3E), 
potentially indicating that KAP1 functions at a step downstream of PIC assembly to control 
transcription activation.
We also examined whether KAP1-7SK snRNP is recruited to an actively transcribed gene 
such as ACTB (encoding β-actin). We found high levels of Cdk9 but much lower levels of 
KAP1, Larp7, and Hexim1 at the promoter, but no significant effect of KAP1 KD on Cdk9 
or Pol II levels at this gene (Figure 3F). This potentially indicates that paused PRGs are 
more sensitive than actively transcribed genes to the loss of KAP1.
Moreover, we observed that KAP1 and the 7SK snRNP also occupied the promoter-
proximal region of the well-known Pol II paused gene HSPA1B (encoding HSP70) (Figure 
S2B) but not at the transcriptionally inactive gene regulated by estrogen in breast cancer 
(GREB1, encoding GREB-1) (Figure S2C) (Bunch et al., 2014; Lis et al., 2000). GREB1 
served as a negative control because it contains neither an assembled PIC nor a 
transcriptionally engaged Pol II, similar to the virtually inactive HIV promoter in the 6.3 and 
2B5 clones (Figures 2F and 2G, respectively).
To further examine how the observed changes in KAP1 and 7SK snRNP occupancy at the 
HIV and cellular genes affect RNA levels from these promoters, we performed qRT-PCR 
assays and observed no significant alterations in NFKBIA or a slight reduction in HIV and 
TNFAIP3 RNA steady-state levels in response to KAP1 KD (Figures 3G–3I) without 
alterations in ACTB levels (Figure 3J).
Taken together, our results demonstrate that recruitment of the 7SK snRNP to promoter-
proximal regions of NF-κB-regulated PRGs is dictated by KAP1.
KAP1-Mediated Recruitment of the 7SK snRNP Complex to Promoter-Proximal Regions 
Enables Efficient Transcription Activation in Response to Stimulation
Given that KAP1 recruits the 7SK snRNP complex to the promoter-proximal regions of 
PRGs regulated by NF-κB, we reasoned that loss of 7SK snRNP from these sites in response 
to KAP1 KD might alter gene induction in response to stimulation. To examine this in 
detail, we monitored transcriptional kinetics of three NF-κB-regulated PRGs (HIV, 
NFKBIA, and TNFAIP3) in response to TNF in the shNT and shKAP1 cell lines (Figure 4). 
Given that in response to TNF, HIV is sequentially activated by NF-κB and the viral 
activator Tat, we used the HIV Tat null cell line 2B2D (Pearson et al., 2008) (here referred 
to as HIV for simplicity) to solely monitor NF-κB activation. Interestingly, we observed a 
sharp decrease in the magnitude of RNA synthesis in response to TNF in the shKAP1 cell 
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line compared to the shNT control (Figure 4A; Figure S3A). Strikingly, this decrease in 
magnitude was also observed, albeit with gene-specific differences, in NFKBIA and 
TNFAIP3 (Figures 4B and 4C; Figures S3B and S3C). The reduced magnitude of RNA 
synthesis demonstrates that KAP1-mediated 7SK snRNP recruitment to the promoter-
proximal regions of PRGs is required for proper gene induction upon stimulation.
To test whether reduced gene activation was due to the inability of NF-κB and Pol II to be 
properly recruited to the promoter in response to stimulation, we treated both cell lines with 
TNF (time points preceding and following the kinetics of RNA synthesis) and monitored 
NF-κB and Pol II occupancy at the three target promoters using ChIP. In response to TNF, 
NF-κB is recruited rapidly and similarly to the three promoters examined in both cell lines, 
albeit with gene-specific differences in kinetics (Figures 4D–4F), but not to their gene 
bodies (Figures 4G–4I).
Whereas the kinetics of NF-κB and Pol II recruitment to the HIV promoter in response to 
TNF was not impaired, Cdk9 recruitment was reduced throughout the time course (>3-fold 
less density in the shKAP1 cell line compared to the shNT control) (Figure 4D). We then 
asked whether this delayed recruitment of Cdk9 to the promoter was also observed in the 
NFKBIA and TNFAIP3 promoters. Consistently, neither NF-κB nor Pol II was affected in 
their recruitment to the two cellular gene promoters in response to TNF (Figures 4E and 4F). 
However, Cdk9 recruitment to these two gene promoters was strongly antagonized in the 
shKAP1 cell line (Figures 4E and 4F). This finding demonstrates that KAP1-mediated 7SK 
snRNP recruitment to promoter-proximal regions (before and after stimulation) facilitates 
the delivery of the P-TEFb kinase to promote gene activation.
To test whether decreased RNA levels were a result of a non-processive Pol II as a 
consequence of delayed Cdk9 recruitment, we again performed ChIP assays after a temporal 
TNF treatment to monitor levels of Cdk9 and Pol II in the gene body of the three PRGs. 
Consistent with the ChIP results at the promoter, Cdk9 and Pol II occupancy in the gene 
body of all three PRGs was decreased in the shKAP1 cell line in response to TNF (Figures 
4G–4I). Notably, reduced Cdk9 and Pol II occupancy in the gene bodies is consistent with 
decreased RNA levels in response to stimulation, indicative of a restriction in productive 
elongation. In the case of HIV and TNFAIP3, more Pol II was recruited to the promoter in 
response to TNF (Figures 4D and 4F). However, this Pol II was not elongation competent, 
because gene body levels were lower in the shKAP1 cell line compared to the shNT control 
for both genes (Figures 4G and 4I), in agreement with the requirement of KAP1 for pause 
release and the low levels of Cdk9 observed in the gene body.
Together, we have established a new role for KAP1 in transcription elongation control 
through deposition of localized, but catalytically inactive, P-TEFb at promoters.
KAP1 Is Dynamically Recruited to Gene Promoters to Enable 7SK snRNP Loading and P-
TEFb Delivery in Response to Stimulation
The finding that KAP1 mediates 7SK snRNP recruitment to promoter-proximal regions in 
basal conditions does not completely explain why more P-TEFb kinase is recruited in 
response to stimulation (to facilitate NF-κB-mediated Pol II pause release). Given that the 
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KAP1-7SK snRNP complex is present both on and off promoters, we hypothesized that 
additional P-TEFb molecules are recruited to act on paused Pol II to facilitate rapid 
elongation upon stimulation. Because KAP1 indirectly interacts with P-TEFb through the 
7SK snRNP (Figure 1), we reasoned that in addition to 7SK snRNP recruitment to the 
promoter-proximal region (which is required for the initial round of elongation), KAP1 
might facilitate recruitment of additional 7SK snRNP molecules during stimulation to 
continuously supply more P-TEFb to facilitate subsequent rounds of elongation (Figure 5A).
We envisioned two potential mechanisms that take place once the promoter-bound 7SK 
snRNP is disassembled upon stimulation and P-TEFb is released to facilitate the initial 
round of elongation: (1) KAP1 remains bound to the promoter to promote the recruitment of 
subsequent 7SK snRNP molecules (Figure 5A, top) or (2) the entire KAP1-7SK snRNP 
complex is continuously resupplied to promoters upon stimulation (Figure 5A, bottom). To 
discern between these two possible mechanisms, we took advantage of our inducible cell 
lines, where KAP1:F (expressed at similar levels to endogenous KAP1; Figure S1A) or 
GFP:F is only expressed in the presence of doxycycline (Figure S1A), and performed 
competition ChIP assays. After a short time induction of KAP1:F and GFP:F, we monitored 
whether there is any KAP1 turnover at promoters after a TNF time-course treatment through 
competition of endogenous KAP1 with induced KAP1:F. In the event that new KAP1-7SK 
snRNP is recruited upon stimulation, the FLAG ChIP signal would increase temporally, 
thereby showing newly synthesized KAP1:F competition with endogenous KAP1 for 
promoter binding. Conversely, if KAP1 remains stably bound at the promoter and more 7SK 
snRNP is recruited upon stimulation, then KAP1:F would not replace promoter-bound 
endogenous KAP1.
We observed that upon stimulation with TNF, KAP1 occupancy at the TNFAIP3 promoter 
remains virtually constant and low to undetectable in the gene body (Figure 5B). However, a 
rapid recruitment of KAP1:F, but not GFP:F, to the promoter is observed, signifying that the 
endogenous KAP1 is being competed off with KAP1:F (Figures 5C and 5D). This 
phenomenon was exclusive to the TNFAIP3 promoter, as there was no difference between 
GFP:F and KAP1:F recruitment to the gene body.
Importantly, as a control, we also examined factor occupancy at the HSPA1B locus, which 
also shows evidence of KAP1 recruitment to the promoter but not to the gene body (Figure 
5E), alongside the 7SK snRNP and paused Pol II (Figure S2B). Because HSPA1B is 
nonresponsive to TNF, we reasoned that no turnover of KAP1 should occur at the promoter 
after stimulation, and therefore KAP1:F should not compete off endogenous KAP1 
assembled at the promoter. Whereas low levels of KAP1:F, but not GFP:F, were detected at 
the promoter before stimulation, like at the TNFAIP3 locus, no additional recruitment of 
KAP1:F was observed upon stimulation (Figures 5F and 5G), indicating that at 
nonresponsive, highly paused genes, KAP1 does not undergo any turnover at the promoter 
in response to stimulation. Notably, Cdk9 levels in the TNFAIP3 promoter and gene body 
(but not at the HSPA1B locus) increase with similar kinetics to KAP1, indicating that they 
are corecruited to the promoter (Figures 5H and 5I).
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Collectively, the data demonstrate that KAP1 is dynamically recruited to promoters in 
response to stimulation to continuously recruit the 7SK snRNP to facilitate gene activation.
KAP1 and the 7SK snRNP Co-occupy Most Gene Promoter-Proximal Regions with Paused 
Pol II
Our results support a model in which KAP1 mediates placement of the 7SK snRNP complex 
to promoter-proximal regions. To obtain genome-wide information, we performed ChIP-seq 
(sequencing) of KAP1, 7SK snRNP components, and Pol II. Given our proposed link 
between active and paused genes and placement of KAP1-7SK snRNP, we used the 
HCT116 cell line to compare levels of Pol II and KAP1-7SK snRNP at promoters with 
transcriptional activity by using the nascent RNA-sequencing data (GRO-seq) generated by 
the Espinosa laboratory (Galbraith et al., 2013).
After ranking all RefSeq genes in the human genome (30,180 unique TSSs) based on 
decreasing promoter Pol II levels, we observed that KAP1 and components of the 7SK 
snRNP co-occupy promoter-proximal regions and that their distribution is very similar to 
Pol II (Figure 6A). Expectedly, the distribution of KAP1-7SK snRNPs at promoter-proximal 
regions also mirrors that of the active chromatin signature (H3K4me3), as well as H3K27ac, 
but not the enhancer signature (H3K4me1) (Figure 6A), which is absent from promoter-
proximal regions (Calo and Wysocka, 2013). Additionally, analysis of the GRO-seq dataset 
sorted based on ranked Pol II occupancy indicates that KAP1 and the 7SK snRNP co-
occupy genes containing transcriptionally engaged Pol II (Figure 6A), including transcripts 
derived from both DNA strands (Figure S4A).
To further define the relative proximity of KAP1 and the 7SK snRNP respective to the TSS, 
we generated metagene profiles. We observed that KAP1 and all 7SK snRNP components 
peak at +200 to +250 bp from the TSS (Figure S4B), slightly downstream of the metagene 
Pol II paused peak located at about +100 bp, in agreement with previous reports (Adelman 
and Lis, 2012; Muse et al., 2007). The location of paused Pol II and KAP1-7SK snRNP also 
matches the expected distribution of the active markers (H3K4me3 and H3K27ac) at 
promoter-proximal regions, which are devoid of H3K4me1 (Figure 6B).
To identify genes regulated by KAP1-7SK snRNP, we first defined 7SK snRNP target genes 
as those marked by three components of the 7SK snRNP (Hexim1, Larp7, and Cdk9) at 
promoter-proximal regions. We used a −250 to +1,000 bp window respective to the TSS 
because we noted that 6,184 genes (20.5% of all annotated genes) contain paused Pol II and 
H3K4me3 peaks in the +251 to +1,000 bp region, possibly indicating that at these genes, Pol 
II can pause further downstream than expected or that their TSS annotations are not accurate 
(see Supplemental Experimental Procedures for complete details). Using these parameters, 
we identified 15,850 7SK snRNP target genes (52.5% of all annotated genes) (Figure 6C). 
Although most of the genes are marked by all three 7SK snRNP components, we are 
probably underestimating this number, due to the absence of one of the three markers from 
some genes based on the high confidence threshold used for peak calling.
Using the previously identified 7SK snRNP target genes, we then determined genes that are 
also marked by KAP1 and paused Pol II in the −250 to +1,000 bp region surrounding the 
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TSS, and where both KAP1 and the 7SK snRNP are within −250 to +250 bp of the Pol II 
peak summit. This filter guarantees that the factors are within a window where Pol II may 
realistically be considered paused, and that they are all within a distance to interact with one 
another. Notably, we found that 12,211 genes (40.5% of all annotated genes and 70.5% of 
genes containing paused Pol II) contained KAP1, the 7SK snRNP, and transcriptionally 
engaged Pol II (Figure 6D), suggesting a significant enrichment of KAP1-7SK snRNP and 
Pol II at promoter-proximal regions (p value < 2.2204−16, machine zero, hypergeometric 
test). We thus refer to these genes as KEC (KAP1-7SK snRNP early elongation complex) 
target genes.
In contrast to KEC target genes, only 551 genes (3.2% of all genes containing paused Pol II) 
completely lack KAP1-7SK snRNP at promoter-proximal regions as defined above, 
indicating significant de-enrichment of genes having paused Pol II but no KAP1-7SK 
snRNP at these sites (p value < 2.2204−16, machine zero, hypergeometric test). Thus, most 
of the times we observed paused Pol II at promoter-proximal regions, we also detected the 
KAP1-7SK snRNP complex.
Inspection of genome browser views reveals examples of KEC target genes such as 
TNFAIP3 (Figure 6E), in agreement with the ChIP-qPCR data generated in Jurkat cells 
(Figure 3), as well as NFKBIA and HSPA1B (Figures S4C and S4D). Moreover, active genes 
such as GAPDH and RPL19 are KEC targets (Figures S4E and S4F), but Pol II and 
KAP1-7SK snRNP distribution extends beyond the promoter-proximal region. Compared to 
transcriptionally paused (TNFAIP3, NFKBIA, and HSPA1B) and active (GAPDH and 
RPL19) genes, transcriptionally inactive genes (IL2 and IL8) did not show evidence of 
KAP1-7SK snRNP assembly or paused Pol II (Figures S4G and S4H), thus supporting the 
previous enrichment analysis.
Our findings that KAP1 occupies most genes containing promoter-proximal Pol II pausing 
prompted us to test the effect of KAP1’s loss on gene expression under basal conditions. For 
this, we created HCT116 shNT and shKAP1 cell lines (showing an ~85% KD) (Figure S4I) 
and used them for qRT-PCR assays to measure steady-state RNA levels. We found that the 
majority of the transcripts examined (GAPDH, NFKBIA, TNFAIP3, HSPA1B, and HSP90) 
have decreased RNA levels in the shKAP1 cell line (Figure S4J). However, MYC, GREB1, 
RPL19, and ACTB did not show any noticeable changes in RNA levels. Although GRO-seq 
experiments will be needed to obtain genome-wide transcription information, the data 
support that KAP1 indeed has an effect in facilitating basal transcription in addition to 
playing a critical role in the activation of PRGs in response to stimulation.
A Model for KAP1-Mediated Recruitment of the 7SK snRNP Complex to Promoter-Proximal 
Regions and Transcription Elongation
Collectively, KAP1-mediated 7SK snRNP recruitment to promoter-proximal regions plays a 
critical role in gene activation. We therefore propose a model in which early transcription 
elongation primes a gene for rapid induction through assembly of the KAP1-7SK snRNP 
complex at these sites. In normal cells, TFs (such as NF-κB) locally capture P-TEFb for 
rapid gene activation in response to induction stimuli through KAP1-mediated placement of 
the 7SK snRNP. Importantly, recruitment of KAP1-7SK snRNP to promoters does not affect 
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the kinetics of TF-promoter DNA interaction in response to stimuli; rather, it facilitates the 
capture of P-TEFb by the TF to promote transcription elongation (initial round). From there, 
additional molecules of promoter-unbound KAP1-7SK snRNP are further recruited to 
promote subsequent rounds of elongation and robust gene induction in response to 
stimulation (Figure 7A). Once P-TEFb is delivered to the promoter, KAP1 might be evicted 
from chromatin or travel with elongating Pol II (to fulfill other downstream functions). This 
step may allow the further recruitment of additional KAP1-7SK snRNP molecules 
(“cycling”) to continuously facilitate elongation.
In KAP1-depleted cells, NF-κB and Pol II are recruited to target gene promoters in response 
to stimuli as well as in normal cells. By contrast, the loss of KAP1 drastically affects P-
TEFb recruitment to promoter-proximal regions, delaying Pol II phosphorylation and 
attenuating both the initial and subsequent rounds of transcription elongation (Figure 7B).
The genome-wide distribution of KAP1-7SK snRNP along with paused Pol II at most 
promoter-proximal regions underscores the importance of this complex in gene activation in 
basal conditions. However, due to the nature of transcriptional activation of constitutive and 
inducible genes, the last set of genes appears to be much more sensitive to the loss of KAP1, 
probably due to their critical requirement of elongation factors for rapid and robust gene 
activation.
DISCUSSION
Several studies have documented that the 7SK snRNP complex is recruited to promoter-
proximal regions (D’Orso and Frankel, 2010; Ji et al., 2013; McNamara et al., 2013). 
However, the molecular basis of this recruitment mechanism and its precise role in the 
transcriptional cycle have yet to be reconciled. In this study, we have established that the 
KAP1 protein physically recruits the 7SK snRNP to the integrated HIV 5′-LTR and most 
cellular gene promoters containing transcriptionally engaged Pol II. Mechanistically, KAP1 
recruits the 7SK snRNP onto chromatin by directly contacting the Larp7 subunit. 
Recruitment of the 7SK snRNP facilitates delivery of P-TEFb to promoters to induce Pol II 
phosphorylation, pause release, and rapid activation of PRGs in response to stimulation.
Besides controlling the rapid induction of PRGs, we showed that KAP1-7SK snRNP is 
deposited at most genes containing promoter-proximal paused Pol II, thus providing a 
critical role in transcriptional homeostasis. We propose that KAP1-mediated localized 
placement of inactive but primed P-TEFb kinase in the vicinity of paused Pol II allows TFs 
to locally capture P-TEFb to couple transcription initiation with elongation. TFs such as NF-
κB bind P-TEFb to stimulate transcriptional elongation by Pol II (Barboric et al., 2001). 
Although TNF stimulation triggers the recruitment of P-TEFb to NF-κB-regulated genes, it 
remains poorly understood whether P-TEFb is tethered to DNA through interaction with the 
TF or through another mechanism. Our findings suggest that P-TEFb is already assembled at 
promoter-proximal regions (even in the absence of the inducible TF) and that additional P-
TEFb is recruited through the KAP1-7SK snRNP interaction in response to stimulation.
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Notably, KAP1-7SK snRNP is recruited to genes containing paused Pol II but not to inactive 
genes. In agreement with this model, chemical inhibition of initiation with triptolide, which 
interferes with formation of the open complex, antagonizes assembly of the KAP1-7SK 
snRNP, PIC assembly at the promoter, and Pol II recruitment and pausing (data not shown). 
This is further exemplified through the use of multiple clonal cell lines containing a single 
HIV integrant in which only viral genomes with transcriptionally engaged Pol II (active 
paused genomes), but not transcriptionally inactive HIV genomes, show evidence of 
KAP1-7SK snRNP assembly. It is noteworthy that this recruitment requires a nucleosome-
free region in the promoter-proximal region and ongoing transcription initiation, because 
proviruses integrated in silent genomic regions (heterochromatin) or transcriptionally 
inactive genes in the human genome do not show evidence of KAP1-7SK snRNP and 
promoter-proximal Pol II pausing.
Whereas our work has focused on the assembly of KAP1-7SK snRNP at promoter-proximal 
regions, one previous study reported that the 7SK snRNP complex occupies distal enhancers 
and plays an important role in transcriptional pause release through a specialized set of 
chromatin-modifying enzymes (Liu et al., 2013). It is thus possible that KAP1-7SK snRNP 
functions from multiple genomic domains (enhancers and promoters) to properly control 
gene activation.
Historically, KAP1 has been functionally linked to epigenetic silencing in embryonic stem 
cells through the deposition of repressive chromatin marks (H3K9me3) and the formation of 
a heterochromatic environment in developmental genes and retro-elements (Rowe et al., 
2010; Wolf and Goff, 2007). However, our findings indicate an additional function of KAP1 
in facilitating the rapid induction of PRGs through recruitment of the 7SK snRNP complex 
to promoter-proximal regions and probably controlling transcription elongation genome-
wide. In the case of the transcriptional silencing function, KAP1 is recruited through 
interaction with the tetrapod-restricted family of KRAB-containing zinc finger proteins 
(Iyengar and Farnham, 2011). Therefore, it would be informative for the field to further 
define the mode of KAP1 recruitment to promoter-proximal regions of all KEC target genes. 
Recently, Bunch et al. reported that KAP1 appears to have single-stranded DNA-binding 
activity (Bunch et al., 2014). Additionally, KAP1 contains a bromodomain that can contact 
acetylated lysine residues on histones, indicating that KAP1 might be recruited by 
contacting DNA and/or chromatin directly. Further examination of these properties is 
needed to precisely ascertain the recruitment mechanism.
Recent work has indicated that the loss of KAP1 triggers a subtle increase in RNA levels in 
basal conditions for a subset of genes (Bunch et al., 2014). Based on these data, the authors 
hypothesized a role for KAP1 in the control of Pol II pausing. Our data (both in basal and 
stimulated conditions) indicate that KAP1 is needed for transcription elongation at most Pol 
II-regulated genes, with the most dramatic effect observed in the attenuation of PRG 
induction in response to stimulation. Although our findings focused on the stimulus-
dependent transcriptional regulation by KAP1, we defined that KEC target genes comprise 
over 40.5% of all annotated genes (70.5% of genes containing paused Pol II). Therefore, 
further work to define how the KEC maintains transcriptional homeostasis would be needed.
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Interestingly, KAP1 belongs to a family of transcriptional regulators known as transcription 
intermediary factor 1 composed of three members: TIF1α/TRIM24, TIF1β/TRIM28, and 
TIF1γ/TRIM33. The TIF1γ member controls erythroid cell fate by regulating transcription 
elongation of a selective small class of genes through P-TEFb (Bai et al., 2010; Rowe et al., 
2010; Tsai et al., 2010). Although it is unknown whether TIF1γ interacts with the 7SK 
snRNP to indirectly recruit P-TEFb to promoters (such as KAP1), TIF1γ’s strikingly high 
homology to KAP1 would support a similar mechanism of interaction (Iyengar and 
Farnham, 2011). Therefore, further work in this arena will enhance our understanding of the 
TIF1/TRIM family in transcription elongation control through the 7SK snRNP.
In conclusion, we have discovered and characterized an unprecedented transcriptional 
signaling network that facilitates the rapid induction of genes upon stimulation. Through the 
KAP1-mediated recruitment of the 7SK snRNP to promoter-proximal regions, we propose 
that the P-TEFb kinase can be activated on site, allowing for proper Pol II pause release. 
This localized placement of transcriptional regulators allows the cell to efficiently respond 
to activating stimuli, a mechanism that HIV has hijacked for rapid viral activation and 
spread.
EXPERIMENTAL PROCEDURES
Cell Culture and Reagents
Standard cell-culture techniques were employed. The primers, plasmids, and antibodies used 
in this study are listed in Tables S3–S5, respectively.
shRNA-Mediated Knockdown, RNA Extraction, and qRT-PCR
RNA isolation and qRT-PCR were performed and analyzed as previously described 
(McNamara et al., 2013).
Immunoprecipitation of Endogenous Proteins
Endogenous proteins were immunopurified with antibodies conjugated to protein G 
Dynabeads (Life Technologies) using routine protocols.
Preparation of Nuclear Extracts for Affinity Purification and Mass Spectrometry
Nuclei from HEK293 T-REx cells inducibly expressing Larp7:S and GFP:S were prepared 
using the Dignam method (Dignam et al., 1983).
LC-MS/MS, Protein Identification, and Quantitation
Samples were analyzed using an in-house data analysis pipeline from the UT Southwestern 
Proteomics service. Table S1 lists the top ten high-confidence Larp7 interactors alongside 
the peptide and coverage calculations. Table S2 lists the proteins identified across all 
samples and provides spectral counts and spectral index values/ratios for all samples/ratios.
Indirect Immunofluorescence
Standard protocols were followed as previously described (McNamara et al., 2013).
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ChIP-qPCR Assays and ChIP-Seq
ChIP assays were performed as previously described (McNamara et al., 2013).
Computational Analysis
All scripting was performed using Python 2.7.6 (http://www.python.org). All ChIP-seq 
binding events were loaded into a custom MySQL database (http://www.mysql.com) to 
allow for efficient comparisons of multiple factors’ binding loci.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• KAP1 recruits 7SK snRNP to most genes containing promoter-proximal paused 
Pol II
• KAP1 delivers inactive P-TEFb kinase to gene promoters for on-site activation
• Inducible pathways rely on KAP1-7SK snRNP for P-TEFb delivery and Pol II 
elongation
• HIV exploits KAP1-7SK snRNP to transcribe its genome in response to 
stimulation
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Figure 1. Identification of KAP1 as an Interactor of the 7SK snRNP Complex
(A) Model for the tethering of the 7SK snRNP complex to a gene promoter containing 
paused Pol II through an as-yet unidentified factor(s) (blue).
(B) Strep affinity purification (AP) of GFP and Larp7 (arrows) from HEK293 T-REx cell 
lines. The top ten high-confidence Larp7 interactors were identified by mass spectrometry 
analysis and are indicated in the silver-stained gel. See also Tables S1 and S2.
(C) A network representation of protein-protein interactions between Larp7 and the factors 
identified in (B).
(D) Stably expressed FLAG-tagged GFP or KAP1 proteins were affinity purified from 
HEK293 T-REx and interactions were analyzed by western blot. Bottom: agarose gels 
showing qRT-PCR amplifications. Input and elution represent 0.5% and 5% of the initial 
material, respectively.
(E) Lysates from HEK293T cells were immunoprecipitated and protein and RNA 
interactions were analyzed by western blot or qRT-PCR, respectively. Input and elution 
represent 0.5% and 10% of the initial material, respectively.
(F) IPs were performed in the absence (−) or presence (+) of RNaseA. Input and elution 
represent 0.5% and 10% of the initial material, respectively. Ethidium bromide stain of 
PCR-amplified 7SK RNA demonstrates the efficiency of RNase treatment.
(G) Full 3D deconvoluted confocal microscopy images showing protein colocalizations in 
U2OS cells.
(H) FLAG-tagged proteins were incubated with immobilized Larp7:S (+) or empty beads 
(−). Note that both KAP1 and Larp7 protein purifications are devoid of any copurifying 7SK 
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RNA (as judged based on qRT-PCR), thus indicating that the interaction is direct and not 
7SK RNA mediated. Input and elution represent 20% of the initial material.
See also Figure S1.
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Figure 2. KAP1 and the 7SK snRNP Complex Co-occupy the HIV Promoter-Proximal Region 
along with Paused Pol II
(A) ChIP assays on the Jurkat HIV E4 clone followed by qPCR using primer pairs 
amplifying six different genomic regions (dots). Maximal ChIP signal was arbitrarily set to 
100%, and all other amplifications were standardized to it (mean ± SEM; n = 3). Amplicons 
marked with an asterisk indicate 5′-LTR or 3′-LTR specific. From each dataset, best-fit 
nonlinear regression curves were generated using Prism (GraphPad) to approximate the 
ChIP signal throughout the HIV genome at a given location. TAR, transactivation response 
element.
(B) ChIP assays with the indicated antibodies including a normal serum (IgG) in the HIV E4 
clone followed by qPCR assays using the 5′-LTR-specific amplicon. Percentage of 
immunoprecipitated DNA respective to input was calculated (mean ± SEM; n = 3).
(C) Same as in (B) for 2B2D.
(D) Same as in (B) for 8.4.
(E) Same as in (B) for 9.2.
(F) Same as in (B) for 6.3.
(G) Same as in (B) for 2B5.
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(H) Quantitation of HIV promoter-proximal transcript levels (+141) normalized to ACTB by 
qRT-PCR (mean ± SEM; n = 3).
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Figure 3. KAP1 Mediates Recruitment of the 7SK snRNP Complex to Promoter-Proximal 
Regions
(A) Western blots of the E4 shNT and shKAP1 cell lines. Values represent relative protein 
levels normalized to β-actin.
(B) Lysates from (A) were immunoprecipitated to monitor levels of 7SK snRNP 
components. Values represent the amount of immunoprecipitated proteins relative to input. 
ND denotes below detection limit.
(C) ChIP assay at the HIV locus in the cell lines from (A). Values represent the average of 
three independent biological replicates minus a nonspecific IgG control (mean ± SEM; n = 
3). Short red lines denote the relative locations of promoter and gene body amplicons.
(D) Same as in (C) for NFKBIA.
(E) Same as in (C) for TNFAIP3.
(F) Same as in (C) for ACTB.
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(G) Relative HIV transcripts (+2,627) quantified by qRT-PCR and normalized to ACTB 
(mean ± SEM; n = 3).
(H) Same as in (G) for NFKBIA.
(I) Same as in (G) for TNFAIP3.
(J) ACTB transcript levels were standardized to 1 for each cell line.
See also Figure S2.
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Figure 4. Loss of KAP1 Reduces P-TEFb Recruitment to Promoters, Thereby Decreasing 
Elongation and Gene Induction in Response to Stimulation
(A) The 2B2D shNT and shKAP1 cell lines were used to monitor HIV (+2,627 amplicons) 
induction after TNF treatment using qRT-PCR. Graphs show fold RNA change ± TNF 
normalized to ACTB (mean ± SEM; n = 3).
(B) Same as in (A) for NFKBIA.
(C) Same as in (A) for TNFAIP3.
(D) ChIP assays at the HIV promoter (mean ± SEM; n = 3).
(E) Same as in (D) for the NFKBIA promoter.
(F) Same as in (D) for the TNFAIP3 promoter.
(G) ChIP assays at the HIV gene body (mean ± SEM; n = 3).
(H) Same as in (G) for the NFKBIA gene body.
(I) Same as in (G) for the TNFAIP3 gene body.
See also Figure S3.
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Figure 5. KAP1 and P-TEFb Are Continuously Recruited to Promoter-Proximal Regions in 
Response to Stimulation
(A) Two potential models of KAP1-7SK snRNP recruitment to promoters and gene 
activation.
(B) HEK293 T-REx cells were treated with TNF and ChIP (KAP1) was performed at the 
TNFAIP3 locus. Error bars represent mean ± SEM (n = 3) throughout the figure.
(C) HEK293 T-REx KAP1:F cells were treated with TNF and ChIP (FLAG) was performed 
at the TNFAIP3 locus.
(D) HEK293 T-REx GFP:F cells were treated with TNF and ChIP (FLAG) was performed 
at the TNFAIP3 locus.
(E) HEK293 T-REx cells were treated with TNF and ChIP (KAP1) was performed at the 
HSPA1B locus.
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(F) HEK293 T-REx KAP1:F cells were treated with TNF and ChIP (FLAG) was performed 
at the HSPA1B locus.
(G) HEK293 T-REx GFP:F cells were treated with TNF and ChIP (FLAG) was performed 
at the HSPA1B locus.
(H) HEK293 T-REx KAP1:F cells were treated with TNF and ChIP (Cdk9) was performed 
at the TNFAIP3 locus.
(I) HEK293 T-REx KAP1:F cells were treated with TNF and ChIP (Cdk9) was performed at 
the HSPA1B locus.
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Figure 6. KAP1 and the 7SK snRNP Co-occupy Most Promoter-Proximal Regions Containing 
Paused Pol II
(A) Heatmap representation of factor distribution at all RefSeq genes relative to the TSS and 
GRO-seq in the HCT116 cell line. All heatmaps are clustered to Pol II.
(B) Metagene analysis showing the distribution of each marker relative to the TSS.
(C) The number of genes containing Hexim1, Larp7, and Cdk9 (7SK snRNP target genes) at 
promoter-proximal regions was calculated.
(D) The number of genes containing the 7SK snRNP, KAP1, and paused Pol II at promoter-
proximal regions was calculated. Genes containing all three markers are referred to as KEC 
target genes.
(E) Genome browser view of ChIP-seq at the KEC target gene TNFAIP3 along with GRO-
seq data showing transcripts from the Watson (blue) and Crick (red) DNA strands.
See also Figure S4.
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Figure 7. Model for the Role of the KAP1-7SK snRNP Complex in Transcriptional Pause 
Release
(A) The KEC is assembled at paused genes. In response to stimulation, NF-κB recognizes 
target promoters and captures P-TEFb released from the KAP1-7SK snRNP. KAP1 and 
inhibitory snRNP components are then evicted from the promoter. These molecular events 
allow for the initial round of elongation through P-TEFb-mediated phosphorylation (P) of 
Pol II (light gray). The promoter-bound KEC facilitates elongation (initial round). Incoming 
pools of KEC provide a continuous source of P-TEFb that phosphorylates newly 
incorporated Pol II (dark gray) to promote productive elongation (subsequent rounds).
(B) Loss of KAP1 results in the elimination of the 7SK snRNP from promoter-proximal 
regions, thereby antagonizing P-TEFb recruitment and attenuating Pol II elongation.
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